Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-12-13

FDA Approved: WOMENS ROGAINE UNSCENTED — Supplemental Application (Kenvue Brands LLC)

View source ↗

Summary

The FDA approved a supplemental application for WOMENS ROGAINE UNSCENTED (minoxidil), enabling an unscented topical formulation for women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • WOMENS ROGAINE UNSCENTED (MINOXIDIL)

Snippet

SUPPL AP for WOMENS ROGAINE UNSCENTED (MINOXIDIL)